Daniel J. Sajkowski - 01 Jul 2026 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2026, 17:27:37 UTC
Prior SEC filing
04 Jun 2026
Next SEC filing
13 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Connor J. Egan, as attorney-in-fact

Key filing fact

Daniel J. Sajkowski filed Form 4 for Calumet, Inc. /DE (CLMT) on 02 Jul 2026.

Key facts

  • This page summarizes Daniel J. Sajkowski's Form 4 filing for Calumet, Inc. /DE (CLMT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2026, 17:27.

Change

  • Previous filing in this sequence was filed on 04 Jun 2026.
  • Current net transaction value: -$153,318.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001619678 Primary reporting owner

Sajkowski Daniel J

Relationship
Director
Address
1060 N CAPITOL AVE, SUITE 6-401, INDIANAPOLIS
Signature
/s/ Connor J. Egan, as attorney-in-fact
Signature date
02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLMT transaction

Common Stock, par value $0.01 per share

Sale

Transaction value
$153,318
Shares
-4,240
Change %
-5.2%
Price
$36.16
Shares after
77,718
Date
01 Jul 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .